-
Register
- User - $27.50
This session will provide an update on legislative health policy changes in the last year that have implications for NP practice. It will also provide an overview of policy implications in the 2020-2030 Future of Nursing Report. Finally, it will provide action steps for NP’s to take to increase the policy advocacy.
Credits: 1.00 contact hours; 0.00 are pharmacology
Expiration Date: December 31, 2024
$27.50
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Discuss the most recent legislative health policy updates affecting nurse practitioners
-Discuss recent SCOTUS decisions that could impact nurse practitioner practice
-Discuss the policy implications of the 2020 – 2030 Future of Nursing Report
Sheldon D. Fields, PhD, RN, CRNP, FNP-BC, AACRN, FAANP, FNAP, FAAN
Associate Dean for Equity and Inclusion and Research Professor
Penn State University, College of Nursing
Dr. Sheldon D. Fields has 30 years of experience in the health sector as an educator, researcher, clinician, administrator, consultant, health policy specialist, and entrepreneur/business owner. He received his Ph.D., in Nursing Science from the University of Pennsylvania, his M.S., in Family Nursing and B.S., in Nursing from Binghamton University. He completed post-doctoral studies at the University of California San Francisco. He is an Advanced AIDS Certified Registered Nurse and a Board-Certified Family Nurse Practitioner. He has held faculty and administrative appointments at Binghamton University, the University of Rochester, Florida International University, Charles R. Drew University of Medicine and Science, New York Institute of Technology, and Long Island University-Brooklyn. He is currently Associate Dean for Equity and Inclusion, Research Professor at Penn State University-College of Nursing.
Dr. Fields is a former director of the Association of Nurses in AIDS Care and an Advanced AIDS Certified Registered Nurse. He is currently First Vice President of the National Black Nurses Association, Inc. He is a fellow of the American Association of Nurse Practitioners, the National Academies of Practice, and the prestigious American Academy of Nursing. He is the founder and CEO of “The S.D.F Group, LLC”, which is a health innovation consultant company.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Sheldon Fields, PhD, RN, FNP-BC, AACRN, FAANP, FNAP, FAAN have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
